Last update Oct. 1, 2025

I am a computational chemist with over 10 years of experience in computer-aided drug design, currently working at a leading pharmaceutical company in Japan. My expertise spans a wide range of drug modalities, where I have not only advanced drug design efforts but also led the development of cutting-edge computational tools and infrastructure to empower medicinal chemists. This includes, but is not limited to, automated docking simulations, QSAR/QSPR predictions, and generative AI for small molecules and biomolecules.

In addition to my technical work, I am deeply interested in exploring broader computational approaches, such as autonomous drug design, free energy calculations, machine-learned force fields, and applications of LLMs beyond computational drug design.

My current focus extends beyond the application of cutting-edge technologies; I am passionate about reimagining how humans interact with these tools and fostering closer integration between experimental and computational disciplines, with the ultimate goal of innovating and advancing the drug discovery process.

Lastly, I am also seeking new avenues where computational science can contribute to human society beyond the realm of drug discovery.